Showing results (121-130 of 2,248) with videos related to
Sort By:
Pageof 225
Current Heart Failure Reports|February 25, 2018
Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical TrialsPrabhjot Singh, Shilpa Vijayakumar, Andreas Kalogeroupoulos, et al.Heart Failure Clinics|November 24, 2011
From risk factors to structural heart disease: the role of inflammationAndreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Javed ButlerThe American Journal of Medicine|August 17, 2019
Salt, No Salt, or Less Salt for Patients With Heart Failure?Muhammad Shahzeb Khan, Daniel W Jones, Javed ButlerCongestive Heart Failure (Greenwich, Conn.)|August 16, 2012
Scope of heart failure hospitalizationJaved Butler, Catherine Marti, Ileana Pina, et al.Circulation|April 13, 2023
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup AnalysisGerasimos Filippatos, Piotr Ponikowski, Dimitrios Farmakis, et al.Drugs|July 4, 2012
Heart failure in hypertension: prevention and treatmentVasiliki V Georgiopoulou, Andreas P Kalogeropoulos, Javed ButlerThe American Journal of Medicine|January 6, 2024
Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart FailureStephen J Greene, Javed Butler, Mikhail N KosiborodProgress in Cardiovascular Diseases|July 25, 2012
Clinical adoption of prognostic biomarkers: the case for heart failureAndreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Javed ButlerHerzschrittmachertherapie & Elektrophysiologie|October 30, 2025
Cardiac contractility modulation: an updateJürgen Kuschyk, Javed Butler, Timothy Fendler, et al.European Journal of Heart Failure|January 12, 2020
Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failureJaved Butler, Yehuda Handelsman, George Bakris, et al.Pageof 225